Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Paul Jourdan of Amati says bitcoin is the modern equivalent of tulip mania. The only reason he can think of for its existence is the benefit to the criminal underworld.
Good luck with MHC in 23.
That's the million dollar question jamrock. Our board and their largest shareholder are very well connected in healthcare (Peter Dines is the relevant expert at Mercia and was on the board at MHC). I'm happy to eave it to them.
2 for me. In this market it’s cheaper to exploit the development work of others than to do the development work yourself. I’d like to see them buy a company with an excellent product or IP but where current management aren’t delivering. I would trust our CEO to turn it around.
MERC sold out of ABDX at IPO. They’re astute guys. I’ve held MERC since covid round 1.
“the fact that we could snap up ABDX with the cash on hand is mind boggling and as jamrock points out, highlights exactly IMO how well this company has handled itself through the pandemic.“
Spot on. Hopefully we’ll get an update in the coming week.
Also we used to have LFT manufacturing capacity in Doncaster, but that was sold to Abingdon Health in April 2020 when their valuation would have been more than ten times ours (unable to get exact figure as it was before their IPO). When ABDX listed in December 2020 they were valued at £92m. We can now cover their market cap with cash in hand. Funny old world.
We were informed they closed the lab acquired with genome store.
We don’t produce tests. We just sell other companies’ tests. LFTs look simple but there’s a lot of tech behind them and they can take months if not years to develop.
Aye, aye barchid. Directors went in twice in the 38/39p area so anticipate a good profit from there.
They won't want to be running this in perpetuity, and in the meantime they're building a good strategic business. Old egg avoiding Jug Ears' Most Loyal Opposition are planning to boost investment in small, high growth businesses via the British Business Bank which would suit MERC fine. You need to see the back of the bish bash bosh Boris rabble first though.
For what it's worth, I can't buy 10,000 online without submitting an order, but I can sell 250,000 above the mid-price at the push of a button. I'm not a reader of tea leaves, but I anticipate another leg up as we continue to close the anomalous big discount to NAV.
Due any time now. Remember what was said in September:
"as we work towards a new portfolio and associated launches, which we are excited to share with the market in Q4."
They flagged up an acquisition to increase AUM at the finals.
Immediately earnings enhancing and initial outlay of 4 x EBITDA looks like better value for shareholders than the last one.
Don't mention the world cup. What were we thinking when we employed Herr Flick as manager?
It’s over and done until English do another u-turn.
Thanks for the pig report, doubt I’ll be subscribing though. Director buy today gives a bit more support.
Interesting presentation this morning. Upturn in China underway with good numbers in October and November. Inventories unwinding which will help cash flow.
I’m in for a scooby snack as well. Looked like the company was due an upturn on chart and fundamentals. I’m interested in their viral treatment research for longer term gains. Avian bird flu, another Chinese export, causing massive distress in farmed and wild birds.
OK you win
It would be wrong to say the tiny director buys are a vote of no confidence in the company. They're a vote of very little confidence.
FD has splashed out with £2300.
Give me a break.
We took out the 100 and 200dma a few weeks ago but didn’t hold. I think we will this time and break the downtrend.